APA (7th ed.) Citation

L, P., C, P., U, A., F, M., F, M., M, Z., . . . AM, V. (2017). Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms. American journal of hematology, 92(2), 187. https://doi.org/10.1002/ajh.24614

Chicago Style (17th ed.) Citation

L, Pieri, et al. "Safety and Efficacy of Ruxolitinib in Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasms." American Journal of Hematology 92, no. 2 (2017): 187. https://doi.org/10.1002/ajh.24614.

MLA (9th ed.) Citation

L, Pieri, et al. "Safety and Efficacy of Ruxolitinib in Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasms." American Journal of Hematology, vol. 92, no. 2, 2017, p. 187, https://doi.org/10.1002/ajh.24614.